Psychiatry & Neurology Doctors in Ridgefield, WA Accepting Medicare

2 Psychiatry & Neurology doctors found. Showing 1 - 2

Hillary Maslin Paulsen, MD Psychiatry & Neurology - Addiction Psychiatry Medicare: Medicare Enrolled Practice Location: 888 S Hillhurst Rd, Ridgefield, WA 98642 Phone: 360-857-0007

Kevin Richard Wandler, MD Psychiatry & Neurology - Addiction Medicine Medicare: Not Enrolled in Medicare Practice Location: 888 S Hillhurst Rd, Ridgefield, WA 98642 Phone: 754-300-3120    Fax: 954-306-8977

News Archive

JDRF partners with the Canadian Government in diabetes research

Juvenile Diabetes Research Foundation (JDRF) Canada is pleased to announce its first partnership with the Government of Canada through the Federal Economic Development Agency of Southern Ontario. Through this innovative two-year partnership, the Government of Canada is committing $20 million and JDRF is making a matching contribution of $10 million to accelerate world-class diabetes research in Southern Ontario by implementing a clinical trial network for diabetes research.

Cardium's Gene Activated Matrix technology demonstrates benefits in periodontal tissue regeneration

Cardium Therapeutics (NYSE Amex: CXM) today reported on preclinical findings published in the scientific journal, Gene Therapy, demonstrating that Cardium's Gene Activated Matrix(TM) or GAM(TM) technology accelerates periodontal tissue regeneration of oral implant-supporting wounds.

USC School of Medicine professor to present keynote on prevention of SBS at Texas conference

On February 28th, Harvey Karp, MD, FAAP, Assistant Professor at the USC School of Medicine, will present the keynote address on the prevention of Shaken Baby Syndrome at the 25th Annual Conference of Prevent Child Abuse Texas, in Dallas.

Doctors have a horrible track record in their profession of recognizing physicians with difficult personalities and dealing with them effectively

Some doctors yell and scream. Some throw surgical instruments. They berate nurses, other health care workers and even patients with snide remarks and insults.

United Therapeutics submits pre-market approval application for use of Remodulin with implantable drug infusion system

United Therapeutics Corporation (NASDAQ: UTHR) announced today that Medtronic, Inc. (NYSE: MDT) has submitted a pre-market approval application to the U.S. Food and Drug Administration (FDA) for the use of Medtronic's SynchroMed® II implantable drug infusion system (including a newly developed catheter) for use with United Therapeutics' Remodulin® (treprostinil) Injection delivered intravenously to patients with pulmonary arterial hypertension.

Read more Medical News

› Verified 2 days ago